Donate

News

 

ABC Interview – Prof Miles Prince

The cancer moonshot: unlocking genetic weapons to defeat cancer

Prof Miles Prince from the Snowdome Foundation was interviewed for the ‘Conversations with Richard Fidler’ radio program which went to air around Australia on Wednesday 31 January on Radio National.

The interview focused on Miles and his work in the area of precision medicine, genetics, and the future of cancer treatments with emphasis on both lymphoma and myeloma.

The interview is now available on podcast: http://www.abc.net.au/radio/programs/conversations/conversations-miles-prince/9359494

The producers have already commented on the amount of listeners who have reacted to the interview – it is worth listening to as it provides a great overview on blood cancer and management.

Professor H. Miles Prince is Professor/Director of Molecular Oncology and Cancer Immunology, Epworth Healthcare. He is also Director, Centre for Blood Cell Therapies, Peter MacCallum Cancer Centre & Professor, Melbourne University, and Monash University.
He is co-founder of Snowdome Foundation of which Lymphoma Australia works alongside and supports.

Sign up to our Newsletter

Back to top
Sign Up
About Us
Lymphoma
Patients
Get Involved
Lymphoma Australia is the only incorporated charity in Australia dedicated to solely providing education, support, awareness and advocacy initiatives for Australians touched by lymphoma and chronic lymphocytic leukemia (CLL).
Copyright © 2025. Lymphoma Australia
Linkedin Spotify
Contact Us
Share This
Cart
Checkout - $0.00
  • 0
  • 1

Contact Lymphoma Australia Today!

Patient Support Hotline

General Enquiries

Please note: Lymphoma Australia staff are only able to reply to emails sent in English language.

For people living in Australia, we can offer a phone translation service. Have your nurse or English speaking relative call us to arrange this.

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.